RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Fisher & Paykel Healthcare Corporation - Stock

Fisher & Paykel Healthcare Corporation Revenue 2024

Fisher & Paykel Healthcare Corporation Revenue

1.74 B NZD

Ticker

FPH.NZ

ISIN

NZFAPE0001S2

WKN

881319

In 2024, Fisher & Paykel Healthcare Corporation's sales reached 1.74 B NZD, a 10.23% difference from the 1.58 B NZD sales recorded in the previous year.

The Fisher & Paykel Healthcare Corporation Revenue history

YEARREVENUE (undefined NZD)GROSS MARGIN (%)
2027e2.4642,42
2026e2.2147,24
2025e1.9852,67
20241.7459,93
20231.5859,35
20221.6862,60
20211.9763,19
20201.2666,14
20191.0766,87
20180.9866,31
20170.8966,01
20160.8263,97
20150.6761,13
20140.6258,61
20130.5655,33
20120.5253,22
20110.5154,87
20100.553,92
20090.4653,76
20080.3650,32
20070.3658,18
20060.32321,85
20050.24434,08

Fisher & Paykel Healthcare Corporation Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Fisher & Paykel Healthcare Corporation, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Fisher & Paykel Healthcare Corporation from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Fisher & Paykel Healthcare Corporation’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Fisher & Paykel Healthcare Corporation. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Fisher & Paykel Healthcare Corporation’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Fisher & Paykel Healthcare Corporation’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Fisher & Paykel Healthcare Corporation’s growth potential.

Fisher & Paykel Healthcare Corporation Revenue, EBIT and net profit per share

DateFisher & Paykel Healthcare Corporation RevenueFisher & Paykel Healthcare Corporation EBITFisher & Paykel Healthcare Corporation Net Income
2027e2.46 B NZD849.86 M NZD493.3 M NZD
2026e2.21 B NZD566.12 M NZD413.07 M NZD
2025e1.98 B NZD462.88 M NZD343.79 M NZD
20241.74 B NZD353.4 M NZD132.6 M NZD
20231.58 B NZD332.2 M NZD250.3 M NZD
20221.68 B NZD505.6 M NZD376.9 M NZD
20211.97 B NZD712.3 M NZD524.2 M NZD
20201.26 B NZD379.3 M NZD287.3 M NZD
20191.07 B NZD292.6 M NZD209.2 M NZD
2018980.8 M NZD269.8 M NZD190.2 M NZD
2017894.41 M NZD240.12 M NZD169.15 M NZD
2016815.49 M NZD211.08 M NZD143.43 M NZD
2015672.35 M NZD170.08 M NZD113.17 M NZD
2014623.4 M NZD143.5 M NZD97.1 M NZD
2013556.3 M NZD112.7 M NZD77.1 M NZD
2012516.7 M NZD92.8 M NZD64.1 M NZD
2011506.1 M NZD97.7 M NZD52.5 M NZD
2010503.3 M NZD99.6 M NZD71.6 M NZD
2009458.7 M NZD102.4 M NZD62.2 M NZD
2008357.9 M NZD58.1 M NZD35.3 M NZD
2007356.5 M NZD89.6 M NZD57.6 M NZD
2006324.5 M NZD104.1 M NZD70 M NZD
2005240.6 M NZD89.7 M NZD61.4 M NZD

Fisher & Paykel Healthcare Corporation stock margins

The Fisher & Paykel Healthcare Corporation margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Fisher & Paykel Healthcare Corporation. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Fisher & Paykel Healthcare Corporation.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Fisher & Paykel Healthcare Corporation's sales revenue. A higher gross margin percentage indicates that the Fisher & Paykel Healthcare Corporation retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Fisher & Paykel Healthcare Corporation's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Fisher & Paykel Healthcare Corporation's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Fisher & Paykel Healthcare Corporation's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Fisher & Paykel Healthcare Corporation. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Fisher & Paykel Healthcare Corporation's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Fisher & Paykel Healthcare Corporation Margin History

Fisher & Paykel Healthcare Corporation Gross marginFisher & Paykel Healthcare Corporation Profit marginFisher & Paykel Healthcare Corporation EBIT marginFisher & Paykel Healthcare Corporation Profit margin
2027e59.93 %34.52 %20.04 %
2026e59.93 %25.6 %18.68 %
2025e59.93 %23.34 %17.34 %
202459.93 %20.28 %7.61 %
202359.35 %21.01 %15.83 %
202262.6 %30.06 %22.41 %
202163.19 %36.14 %26.59 %
202066.14 %30.02 %22.73 %
201966.87 %27.34 %19.54 %
201866.31 %27.51 %19.39 %
201766.01 %26.85 %18.91 %
201663.97 %25.88 %17.59 %
201561.13 %25.3 %16.83 %
201458.61 %23.02 %15.58 %
201355.33 %20.26 %13.86 %
201253.22 %17.96 %12.41 %
201154.87 %19.3 %10.37 %
201053.92 %19.79 %14.23 %
200953.76 %22.32 %13.56 %
200850.32 %16.23 %9.86 %
200758.18 %25.13 %16.16 %
200659.93 %32.08 %21.57 %
200559.93 %37.28 %25.52 %

Fisher & Paykel Healthcare Corporation Aktienanalyse

What does Fisher & Paykel Healthcare Corporation do?

The Fisher & Paykel Healthcare Corporation Ltd is a New Zealand company that manufactures medical devices and equipment for use in intensive care and sleep apnea therapy. The company was founded in 1934 by Sir Woolf Fisher and Maurice Paykel in Auckland and has been listed on the Australian stock exchange since 2001. The company's business model is focused on developing and manufacturing innovative medical products that can improve the lives of patients in intensive care and sleep apnea therapy. The company specializes in producing high-quality products that are easy to use and maintain. The products are available in different price and performance ranges to meet the varying needs of patients. Fisher & Paykel Healthcare operates three business segments: Sleep Apnea, Hospital, and Homecare. The Sleep Apnea segment produces and markets CPAP (Continuous Positive Airway Pressure) devices and masks. CPAP devices are used to maintain pressure in the airways during sleep, which can help protect patients from breathing interruptions. The masks are placed on the patient's face to maintain pressure on the airways. Fisher & Paykel Healthcare also offers a wide range of other CPAP products, such as accessories and consumables. The Hospital segment specializes in the production and distribution of medical accessories for hospitals. This includes ventilators, oxygen therapy devices, and moisture and heat exchangers. These products are used in intensive care to support patients who are unable to breathe on their own or require extrapulmonary oxygenation. In the Homecare segment, Fisher & Paykel Healthcare offers medical devices and accessories for home care. This includes CPAP devices for sleep apnea therapy, as well as other devices for respiratory tract infections and aerosol therapy. The company also offers accessories for caregivers and for rehabilitation and elderly care facilities. Over the years, Fisher & Paykel Healthcare has received numerous awards for its innovative products. For example, the Eson nasal mask range was nominated for the internationally renowned Red Dot Design Award in 2012. The company is also committed to using environmentally friendly materials and manufacturing processes to minimize the environmental impact of its products. Overall, Fisher & Paykel Healthcare Corporation Ltd. has developed a business model that specializes in the development of high-quality products. In particular, the three segments of Sleep Apnea, Hospital, and Homecare allow the company to manufacture a wide range of medical devices and accessories to meet different customer requirements. This has enabled the company to achieve a leading position in the global medical technology market. Fisher & Paykel Healthcare Corporation ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Fisher & Paykel Healthcare Corporation's Sales Figures

The sales figures of Fisher & Paykel Healthcare Corporation originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Fisher & Paykel Healthcare Corporation’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Fisher & Paykel Healthcare Corporation's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Fisher & Paykel Healthcare Corporation’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Fisher & Paykel Healthcare Corporation Stock

How much revenue did Fisher & Paykel Healthcare Corporation generate this year?

Fisher & Paykel Healthcare Corporation has achieved a revenue of 1.74 B NZD this year.

How much was the turnover of the company Fisher & Paykel Healthcare Corporation compared to the previous year?

The revenue of Fisher & Paykel Healthcare Corporation has increased by 10.23% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Fisher & Paykel Healthcare Corporation?

The revenue of Fisher & Paykel Healthcare Corporation is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Fisher & Paykel Healthcare Corporation measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Fisher & Paykel Healthcare Corporation so important for investors?

The revenue of Fisher & Paykel Healthcare Corporation is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Fisher & Paykel Healthcare Corporation pay?

Over the past 12 months, Fisher & Paykel Healthcare Corporation paid a dividend of 0.37 NZD . This corresponds to a dividend yield of about 1.23 %. For the coming 12 months, Fisher & Paykel Healthcare Corporation is expected to pay a dividend of 0.39 NZD.

What is the dividend yield of Fisher & Paykel Healthcare Corporation?

The current dividend yield of Fisher & Paykel Healthcare Corporation is 1.23 %.

When does Fisher & Paykel Healthcare Corporation pay dividends?

Fisher & Paykel Healthcare Corporation pays a quarterly dividend. This is distributed in the months of January, July, January, July.

How secure is the dividend of Fisher & Paykel Healthcare Corporation?

Fisher & Paykel Healthcare Corporation paid dividends every year for the past 23 years.

What is the dividend of Fisher & Paykel Healthcare Corporation?

For the upcoming 12 months, dividends amounting to 0.39 NZD are expected. This corresponds to a dividend yield of 1.32 %.

In which sector is Fisher & Paykel Healthcare Corporation located?

Fisher & Paykel Healthcare Corporation is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fisher & Paykel Healthcare Corporation kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fisher & Paykel Healthcare Corporation from 7/10/2024 amounting to 0.368 NZD, you needed to have the stock in your portfolio before the ex-date on 6/26/2024.

When did Fisher & Paykel Healthcare Corporation pay the last dividend?

The last dividend was paid out on 7/10/2024.

What was the dividend of Fisher & Paykel Healthcare Corporation in the year 2023?

In the year 2023, Fisher & Paykel Healthcare Corporation distributed 0.642 NZD as dividends.

In which currency does Fisher & Paykel Healthcare Corporation pay out the dividend?

The dividends of Fisher & Paykel Healthcare Corporation are distributed in NZD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Fisher & Paykel Healthcare Corporation

Our stock analysis for Fisher & Paykel Healthcare Corporation Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fisher & Paykel Healthcare Corporation Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.